Search results
Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 1 day agoStockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell ...
Breaking Barriers in Bioprocessing: An Interview with Himanshu Gadgil, CEO of Enzene Biosciences
BioPharma-Reporter· 21 hours agoWith a rich background in biochemistry and extensive experience in the pharmaceutical industry,...
ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $87.00 at HC Wainwright
ETF DAILY NEWS· 1 day agoANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target lifted by HC Wainwright from $83.00 to $87.00 in a research note issued to investors on Monday, Benzinga ...
FY2028 EPS Estimates for Madrigal Pharmaceuticals, Inc. Lowered by Analyst (NASDAQ:MDGL)
ETF DAILY NEWS· 1 day agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Equities research analysts at HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Madrigal ...
FY2027 EPS Estimates for Marinus Pharmaceuticals, Inc. Decreased by Analyst (NASDAQ:MRNS)
ETF DAILY NEWS· 1 day agoMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) – Stock analysts at HC Wainwright reduced their FY2027 EPS estimates for Marinus Pharmaceuticals
Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 16 hours agoEledon Pharmaceuticals (ELDN) might move higher on growing optimism about its earnings prospects,...
The impact of smart packaging in pharmaceutical logistics
Packaging Gateway via Yahoo Finance· 7 days agoIn the pharmaceutical industry, logistics is not just about transportation but ensuring that...
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 6 days agoThe company's shares are up 13% from a week ago. Risk Analysis Before you take the next step you...
Examining the Potential Price Growth of Ironwood Pharmaceuticals Inc
Knox Daily· 1 day agoIn a filing, Ironwood Pharmaceuticals Inc revealed its Director Duane Jon R acquired Company’s shares for reported $60204.0 on Mar 06 ’24. In the deal valued at $8.70 per ...
Rigel Pharmaceuticals’s latest rating changes from various analysts – Knox Daily
Knox Daily· 1 day agoRigel Pharmaceuticals’s recently made public that its CEO, President RODRIGUEZ RAUL R unloaded Company’s shares for reported $34821.0 on Feb 05 ’24. In the deal valued at ...